Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2020 | 1 |
2023 | 0 |
Search Results
2 results
Results by year
Page 1
ER membranes associated with mitochondria: Possible therapeutic targets in heart-associated diseases.
Pharmacol Res. 2020 Jun;156:104758. doi: 10.1016/j.phrs.2020.104758. Epub 2020 Mar 18.
Pharmacol Res. 2020.
PMID: 32200027
Review.
In this review, we highlight MAMs' alterations mainly in cardiomyocytes, linked with cardiovascular diseases, such as cardiac ischemia-reperfusion, heart failure, and dilated cardiomyopathy. We also describe proteins that are part of the MAMs' machinery, as the FUN1 …
In this review, we highlight MAMs' alterations mainly in cardiomyocytes, linked with cardiovascular diseases, such as cardiac ischemia-reper …
Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control?
Grieve DJ, Cassidy RS, Green BD.
Grieve DJ, et al.
Br J Pharmacol. 2009 Aug;157(8):1340-51. doi: 10.1111/j.1476-5381.2009.00376.x.
Br J Pharmacol. 2009.
PMID: 19681866
Free PMC article.
Review.
GLP-1 receptors (GLP-1Rs) are expressed in the heart and vasculature of both rodents and humans, and recent studies have demonstrated that GLP-1R agonists have wide-ranging cardiovascular actions, such as modulation of heart rate, blood pressure, vascular tone and myocardi …
GLP-1 receptors (GLP-1Rs) are expressed in the heart and vasculature of both rodents and humans, and recent studies have demonstrated that G …
Item in Clipboard
Cite
Cite